P68 is a potent inhibitor of protein synthesis in virally infected cel
ls and has been suggested to function in noninfected cells as a tumor
suppressor gene. We have previously demonstrated that p68 expression c
orrelates directly with cellular differentiation and inversely with pr
oliferative activity in normal epithelium and in several human tumor s
ystems. In order to determine the role of p68 in human breast cancer,
we utilized immunohistochemistry and mapped the expression of p68 in t
issue from 200 breast biopsy specimens. A total of 434 foci, ranging f
rom normal breast tissue to infiltrating carcinoma were examined. We f
ound that p68 was present at basal levels in normal lobular and lumina
l ductal epithelial cells, with higher levels present in myoepithelial
cells. Nonproliferative fibrocystic lesions showed variable expressio
n of p68, with high levels seen within foci of apocrine metaplasia and
low levels in cystically dilated terminal duct units. Low levels of p
68 were seen in typical ductal proliferations, lobular neoplasia (atyp
ical lobular hyperplasia and lobular carcinoma in situ), and in fibroa
denomas. Foci of atypical ductal hyperplasia in situ and invasive duct
al carcinoma generally showed higher levels of p68 expression. Among t
he infiltrating carcinomas, p68 expression correlated with nuclear gra
de. This suggests that the ability of p68 to inhibit cellular prolifer
ation may be impaired in breast cancer and that its expression, althou
gh modestly Paralleling cellular differentiation, is not a predictive
indicator of improved survival.